In light of the above considerations, in light of the unfavorable risk/benefit ratio presented by pseudoephedrine associated with its addictive potential, there appear no valid reasons for its systematic use in obesity of any order and degree
In clinical trials, people taking oral semaglutide lost weight, and higher doses studied have shown losses of up to 15% of body weight when paired with healthy habits like balanced eating and regular activity
Both in vivo and in vitro studies provide substantial evidence of the neuroprotective benefits of GLP-1RAs through the modulation of inflammation, mitochondrial function, ROS, tau hyperphosphorylation, and anti-apoptotic pathways
Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes
XiaoDWangXLiangWYangYDuYLiuCet al